Christophe Fermé
Departement of Medecine
Institut Gustave Roussy
39 rue C Desmoulins
94805 Villejuif Cedex
France
Name/email consistency: high
- Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Fermé, C., Mounier, N., Casasnovas, O., Brice, P., Divine, M., Sonet, A., Bouafia, F., Bastard-Stamatoullas, A., Bordessoule, D., Voillat, L., Reman, O., Blanc, M., Gisselbrecht, C. Blood (2006)
- Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. Fermé, C., Mounier, N., Diviné, M., Brice, P., Stamatoullas, A., Reman, O., Voillat, L., Jaubert, J., Lederlin, P., Colin, P., Berger, F., Salles, G. J. Clin. Oncol. (2002)
- Current clinical trials for the treatment of adult advanced-stage Hodgkin's disease: GELA experiences. Groupe d'Etudes des Lymphomes de l'Adulte. Ferme, C., Mounier, N., Diviné, M. Ann. Oncol. (2002)